Jakarta, 25 July 2022,  PT Kalbe Farma Tbk (“Kalbe”) is pleased to announce the signing of a Share Purchase Agreement (“SPA”) that took place on 22 July 2022, between Sanofi (Sanofi Aventis Participations and Hoechst GMBH) as Sellers and Kalbe as Purchaser. The SPA outlined the agreement between Kalbe and Sellers to transfer the majority share ownership in PT Aventis Pharma, which is expected to be effectively implemented in Q4 2022 subject to the fulfillment of certain conditions as part of the SPA.

Jakarta, July 23rd, 2022 – PT Kalbe Farma Tbk (Kalbe), through its subsidiary Kalbe Ethical Customer Care (KECC), has revealed accurate ways to protect the children regarding their health problems, in commemoration with the 2022 National Children’s Day.

Jakarta, July 19th, 2022 – Near the Ied Qurban, PT Kalbe Farma Tbk (Kalbe) revealed several educative tips in preventing the cholesterol level after consuming meat. There is an interesting fact that goat meat has a lower level of cholesterol compared with beef and chicken.

Jakarta, July 16th, 2022 – PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Mostrans Global Digilog, continues to innovate in developing products and services for quality deliveries supported the technology. A digital acceleration is also essential for achieving a reliable performance in logistic and transportation sectors.

Jakarta, July 15th, 2022 – PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Sanghiang Perkasa (Kalbe Nutritionals) and YARSI University, has agreed to conduct a collaboration of nutrient intervention for pregnant women in order to quickly decrease stunting cases. This program will be conducted in Kresek, Tangerang Region, Banten, from July until Desember of 2022.